Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chris Nolet currently holds 13,562 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chris Nolet has been a net neutral trader of RVNC stock. They have purchased $0 and sold $0 worth of shares.
Chris Nolet's most recent insider trade was on Jun 18, 2026, when they sold 13,562 shares at $0.00 per share.
Chris Nolet serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 13 insider transactions totaling $0 over their tenure at the company.
Chris Nolet holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Chris Nolet has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Chris Nolet was on Jun 18, 2026, when they purchased $0 worth of AVBP shares. This transaction involved 13,562 shares at N/A per share.
Chris Nolet currently owns 13,562 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chris Nolet's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chris Nolet has 13 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Chris Nolet and 40,000+ other insiders.